Industry News

Industry News

Link Between Heart Damage After Chemo And Stress In Cardiac Cells

May 23, 2012

Blocking a protein in the heart that is produced under stressful conditions could be a strategy to prevent cardiac damage that results from chemotherapy, a new study suggests. Previous research has suggested that up to a quarter of patients who receive the common chemotherapy drug doxorubicin are at risk of developing heart failure later in life... Read More

Discovery Suggests New Combination Therapy Strategy For Basal-Like Breast Cancers

May 23, 2012

Multiple research projects - including a 2006 study conducted at the University of North Carolina at Chapel Hill - have used DNA microarray analysis to identify several breast cancer subtypes, including luminal A, luminal B, basal-like and HER2-enriched. Simple tests are being developed to help doctors identify these subtypes and to treat their patients in a more biologically-based way... Read More

Discovery Suggests New Combination Therapy Strategy For Basal-Like Breast Cancers

May 23, 2012

Multiple research projects - including a 2006 study conducted at the University of North Carolina at Chapel Hill - have used DNA microarray analysis to identify several breast cancer subtypes, including luminal A, luminal B, basal-like and HER2-enriched. Simple tests are being developed to help doctors identify these subtypes and to treat their patients in a more biologically-based way... Read More

Prostate Growth May Be Slowed By Statins

May 23, 2012

Statins drugs prescribed to treat high cholesterol may also work to slow prostate growth in men who have elevated PSA levels, according to an analysis led by researchers at Duke University Medical Center. The finding, presented at the annual meeting of the American Urological Association, provides additional insight into the effects of cholesterol-lowing drugs such as statins on the prostate... Read More

Prostate Growth May Be Slowed By Statins

May 23, 2012

Statins drugs prescribed to treat high cholesterol may also work to slow prostate growth in men who have elevated PSA levels, according to an analysis led by researchers at Duke University Medical Center. The finding, presented at the annual meeting of the American Urological Association, provides additional insight into the effects of cholesterol-lowing drugs such as statins on the prostate... Read More

Sigmoidoscopy Reduces Colorectal Cancer Rates

May 23, 2012

Flexible sigmoidoscopy, a screening test for colorectal cancer that is less invasive and has fewer side effects than colonoscopy, is effective in reducing the rates of new cases and deaths due to colorectal cancer, according to research sponsored by the National Cancer Institute, part of the National Institutes of Health... Read More

Adding Vitamin D To BCG Vaccine To Fight Bladder Cancer

May 23, 2012

The tuberculosis vaccine is often used as a treatment for bladder cancer, and adding vitamin D might improve the vaccine's effectiveness, according to new research from the University of Rochester Medical Center presented today at the American Urological Association annual meeting. Yi-Fen Lee, Ph.D... Read More

New Cancer Therapies Likely Following 'Orphan' Sleep Drug Findings

May 23, 2012

An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center. Their novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more-effective cancer therapies... Read More

New Cancer Therapies Likely Following 'Orphan' Sleep Drug Findings

May 23, 2012

An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center. Their novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more-effective cancer therapies... Read More

Levels Of Sex Hormones Linked To Breast Cancer Risk Reduced By Moderate Weight Loss

May 23, 2012

Even a moderate amount of weight loss can significantly reduce levels of circulating estrogens that are associated with an increased risk of breast cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center - the first randomized, controlled clinical trial to test the effects of weight loss on sex hormones in overweight and obese postmenopausal women,... Read More

Previous Page   Next Page